ClinicalTrials.Veeva

Menu

Neuromodulatary Efficacy of Transcranial Direct Current Stimulation in Severe Refractory Primary Dysmenorrhea

T

Taipei Veterans General Hospital

Status

Completed

Conditions

Primary Dysmenorrhea

Treatments

Device: Active tDCS
Device: Sham tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT03608215
2015-01-005B

Details and patient eligibility

About

Primary Dysmenorrhea (PDM), defined as menstrual pain without discernable organic causes, is inexorably common in adolescent women, about 40-90% of women may suffer from it, and 20% of them can be severe in the context of being refractory to medication, daily function impairment, and having pain of severe degree. Novel therapeutic method is in need for pain alleviation for this particular phenotype. It has been reported that PDM females may engage motor-cortex based descending pain modulation system in our resting-state functional Magnetic Resonance Imaging (rs-fMRI) and thermal pain-activation fMRI studies. Based on the reported analgesic efficacy of transcranial Direct Current Stimulation (tDCS) on the motor cortex for various experimental painful conditions and clinical pain disorders, it is plausible that tDCS can be effective for the severe and medication-refractory PDM patients. This study aim to investigate the analgesic efficacy of tDCS in severe PDMs and to elucidate the dynamic brain neuroplasticity in the context of experimental pain after tDCS intervention. Thirty severe PDMs will be recruited and randomly allocated to either real or sham group in a triple-blind manner. Experimental pain electrical stimulation will be performed before and after the tDCS intervention. The experimental pain-evoked magnetoencephamographic (MEG) data will be correlated with behavioral and psychological measurements. This is the first study in the literature investigating the tDCS efficacy for acute pain in severe PDM. The result can promise a new possibility for clinical application.

Enrollment

31 patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 20-35 years old PDM patients
  • Right-handedness
  • A regular menstrual cycle: 27-32 days
  • Cramping pain during the menstrual period in the last 6 months , VAS ≧ 7
  • Abstinence for daily activities due to PDM
  • Need analgesic or Physical therapy despite of no prominent effect

Exclusion criteria

  • History of head injury
  • Pathological pituitary gland disease
  • Organic pelvic disease, psychiatric disorder
  • Pregnancy, childbirth
  • A metal or pacemaker implant.
  • Take hormone agents within 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

31 participants in 2 patient groups

Active tDCS
Experimental group
Description:
The anode sponge electrode will be placed on the scalp over the left primary motor cortex (M1) and the cathode sponge electrode will be positioned over the right supraorbital cortex (SO). Active stimulation consists of 2 mA current applied continuously for 20 minutes.
Treatment:
Device: Active tDCS
Sham tDCS
Sham Comparator group
Description:
The anode sponge electrode will be placed on the scalp over the left primary motor cortex (M1) and the cathode sponge electrode will be positioned over the right supraorbital cortex (SO). The 2 mA current will be applied for 30 seconds at the beginning of the session.
Treatment:
Device: Sham tDCS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems